Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 19.77M P/E - EPS this Y - Ern Qtrly Grth -
Income -752.85k Forward P/E - EPS next Y - 50D Avg Chg -9.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg 51.00%
Dividend N/A Price/Book 65.00 EPS next 5Y - 52W High Chg -54.00%
Recommedations - Quick Ratio 9.61 Shares Outstanding 50.70M 52W Low Chg 680.00%
Insider Own - ROA -123.30% Shares Float 33.83M Beta 4.11
Inst Own - ROE -156.07% Shares Shorted/Prior -/- Price 0.39
Gross Margin - Profit Margin - Avg. Volume 100,393 Target Price -
Oper. Margin - Earnings Date - Volume 64,215 Change 11.43%
About VITALITY BIOPHARMA INC

Vitality Biopharma, Inc. focuses on developing cannabinoid pharmaceutical prodrugs in the United States. The company produces approximately 25 novel cannabosides, including glycosylated tetrahydrocannabinol (THC), cannabidiol, cannabidivarin, and cannabinol. It is developing THC-glycoside (VBX-100), an oral prodrug for the treatment of gastrointestinal diseases, including inflammatory bowel disease and irritable bowel syndrome. The company was formerly known as Stevia First Corp. and changed its name to Vitality Biopharma, Inc. in July 2016. Vitality Biopharma, Inc. was incorporated in 2007 and is headquartered in Los Angeles, California.